Back

Treatment patterns of heart failure patients with reduced or mildly reduced ejection fraction on dapagliflozin: baseline data from the 3rd interim analysis of two EVOLUTION-HF DEallEF study cohorts

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Challenges and solutions in guideline-directed therapy in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Matthias Paul

Muenster (Germany)

5 More presentations in this session

Presentation thumbnail
Effect of GDMT optimization on KDIGO risk categories in HFrEF
Doctor N. Panagiotides (Vienna, AT)
Abstract
Presentation thumbnail
Intravenous iron therapy in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Doctor R. Ali (Pembroke Pines, US)
Abstract
Presentation thumbnail
Real-word elegibiliy and tolerability of vericiguat in HFrEF: data from a multicenter registry
Associate Professor S. Nodari (Brescia, IT)
Abstract
Presentation thumbnail
Comparison of the 2016 and 2025 ASE/EACVI Guidelines on HFpEF
Miss W. Hu (Hangzhou, CN)
Abstract
Presentation thumbnail
Bridging inequity in HFpEF care: pilot project experience informing the design and implementation of a multidisciplinary blueprint
Doctor M. Lee (Glasgow, GB)
Abstract

Access the full session

Session thumbnail
Challenges and solutions in guideline-directed therapy in heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Mitral regurgitation, atrial fibrillation, and HFpEF: a three-headed dragon

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources